How is “novelty” characterized by CIMIT reviewers?
CIMIT rarely supports novel science or engineering as normally interpreted in those disciplines because such projects typically require many years of development before they may be considered for use in medicine. Rather, CIMIT seeks the novel application of technology which is built on stable (hopefully, commercially available) platforms. Thus the novelty is in the application to a particular medical problem.
